This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides actionable information across new developments in prebiotics, immunology, oncology, cell and gene therapies, antibody therapies, and precision medicine approaches. The TOE also encompasses technology advances across the use of AI and ML in drug discovery and development.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

• In what ways are advances in prebiotics, immunology, oncology, cell and gene therapies, and antibody therapies reshaping the future of health and wellness?
• Which emerging technologies in genetic engineering, biomarkers, tissue engineering, synthetic biology, and microbiome are poised to redefine the next era of life sciences?
• Which key innovations in regenerative medicine, nanomedicine, nutrition, cosmetic procedures, and more are driving transformational growth in healthcare and wellness?